Worcestor, MA, United States of America

James Kappelman


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 75(Granted Patents)


Location History:

  • Worcestor, MA (US) (2002)
  • Worcester, MA (US) (2002)

Company Filing History:


Years Active: 2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of James Kappelman in Interferon Research

Introduction

James Kappelman is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of interferon research. With a total of two patents to his name, Kappelman's work focuses on the isolation and purification of natural type I interferons derived from leukocytes.

Latest Patents

Kappelman's latest patents revolve around the compositions of highly-purified natural mixtures of type I interferon. These inventions detail methods for isolating these interferons from white blood cells. The highly-purified mixtures include at least nine subtypes, such as alpha-1, alpha-2, alpha-5, alpha-7, alpha-8, alpha-10, alpha-14, alpha-21, and omega. This results in the creation of at least 16, and possibly 20 or more molecular species, which are crucial for various therapeutic applications.

Career Highlights

Kappelman is associated with Viragen Incorporated, a company that focuses on biopharmaceuticals. His work has been instrumental in advancing the understanding and application of interferons in medical treatments. His innovative approaches have paved the way for new methodologies in the field.

Collaborations

Kappelman has collaborated with notable coworkers such as Joseph P. Morris and Duy Nguyen. Their combined expertise has contributed to the successful development of Kappelman's patents and innovations.

Conclusion

James Kappelman's contributions to the field of interferon research highlight the importance of innovation in biotechnology. His patents reflect a commitment to advancing medical science through the development of highly-purified natural mixtures of type I interferon.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…